Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gramicidin (substance) |
Inferred relationship |
Some |
|
Product containing gramicidin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gramicidin (substance) |
Inferred relationship |
Some |
1 |
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gramicidin (substance) |
Inferred relationship |
Some |
|
Gramicidin d |
Is a |
False |
Gramicidin (substance) |
Inferred relationship |
Some |
|
Product containing gramicidin and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gramicidin (substance) |
Inferred relationship |
Some |
2 |
Product containing gramicidin in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gramicidin (substance) |
Inferred relationship |
Some |
|
Product containing gramicidin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gramicidin (substance) |
Inferred relationship |
Some |
|
Gramicidin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gramicidin (substance) |
Inferred relationship |
Some |
1 |
Gramicidin-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gramicidin (substance) |
Inferred relationship |
Some |
1 |
Gramicidin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gramicidin (substance) |
Inferred relationship |
Some |
1 |
Gramicidin and neomycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gramicidin (substance) |
Inferred relationship |
Some |
2 |
Gramicidin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gramicidin (substance) |
Inferred relationship |
Some |
1 |
Product containing only gramicidin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gramicidin (substance) |
Inferred relationship |
Some |
1 |
Gramicidin d |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Gramicidin (substance) |
Inferred relationship |
Some |
|